Sphere Fluidics patents Cyto-Mine System and Cyto-Cartridge
Sphere Fluidics has just filed a UK patent on the emerging Cyto-Mine system, that will perform high-throughput, novel single cell assays, and associated Cyto-Cartridge designs. “The latter are complex, biochip structures that will enable unique single cell, cell-cell assays and improved monoclonality for biopharmaceutical discovery and development”, said Dr Marian Rehak (R&D Director). “This filing is a key patent that emphasises our strategy of protecting important elements of our single cell analysis systems”, said Dr Frank F. Craig (CEO). “We now have 12 patent families in our portfolio, many of them invented by the Sphere Fluidics’ R&D team”.